Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Related Posts Ganfeng Chairman’s Forecast Sparks Lithium Price Surge in China November 18, 2025 Apollo Silver Grants Incentive RSUs November 18, 2025 Cartier Metallurgical Testwork Program is Underway at Cadillac November 18, 2025